Clinical trial
Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)
NCT00006496 · Massachusetts General Hospital, Other · Active, not recruiting
Key facts
| NCT number | NCT00006496 |
|---|---|
| Title | Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS) |
| Official title | Molecular Epidemiology of Acute Respiratory Distress Syndrome |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Acute Respiratory Distress Syndrome, Lung Diseases |
| Enrollment | 4,000 |
| Start date | Feb 1, 2000 |
| Primary completion | Aug 1, 2026 |
| Completion | Dec 1, 2026 |
| First posted | Nov 17, 2000 |
| Last update posted | Nov 29, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: